Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Rajiv Kaul
Manager Tenure 16 Years

Strategy And Objective

The fund seeks capital appreciation. Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Net Asset Value

as of 5:25 PM ET 10/15/2021

Performance

  • 1 Week
  • +1.25%
  • 1 Month
  • -5.97%
  • 3 Months
  • +0.46%
  • 1 Yr Return
  • -12.69%
  • 5 Yr Return
  • +24.77%

Equity Sector Breakdown

Health 71.31%
Services 7.95%
Technology 0.26%
IndustrialCyclical 0.09%
ConsumerDurables n/a
Energy n/a
Finance n/a
NonDurables n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.16%
ForeignStocks 7.07%
Convertible 2.17%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 7.70 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -2.28 -2.42 3.27
Beta 1.00 1.05 1.12
R Squared 0.54 0.46 0.36
Std Deviation 25.57 23.61 24.63
Sharpe Ratio 0.55 0.64 n/a

Purchase Information

as of 5:12 PM ET 10/14/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 09/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 09/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +14.88%
  • +14.88%
+14.88% +14.88%
3 Year
  • +11.73%
  • +11.73%
+11.73% +11.73%
10 Year
  • +20.03%
  • +20.03%
+20.03% +20.03%
Life Of Fund
  • +13.58%
  • +13.58%
+13.58% +13.58%

Top 10 Holdings

Symbol Company Name % Of Assets
VRTX VERTEX PHARMACEUTICALS INC 4.46%
BGEN BIOGEN INC 3.54%
ALNY ALNYLAM PHARMACEUTICALS INC 2.65%
MRNA MODERNA INC 2.34%
ABBV ABBVIE INC 14.49%
ARGX ARGENX SE 1.64%
XLRN ACCELERON PHARMA INC 1.58%
BPMC BLUEPRINT MEDICINES CORPORAT 1.55%
TGTX TG THERAPEUTICS INC 1.29%
MRTX MIRATI THERAPEUTICS INC 1.28%

LATEST NEWS

Recent Articles from TheStreet

Chinese Medical Device Maker Contec Rides Pandemic Demand To Score 12-fold Share Price Gain On Shenzhen Debut

Cramer: Sharecare’s Low Share Price Makes the Stock Worth a Look

Technical indicators for health tech company's shares appear to be improving.

united-airlines (2)

United Airlines COVID-19 Vaccine Mandate Prompts Judge's TRO

United Airlines temporarily can't force employees to take unpaid leave if they have a medical or religious excuse from taking the COVID-19 vaccine.

SPAC Lead

Digital Asset Firm Bakkt Completes SPAC Merger With VPC

Digital asset marketplace and wallet provider Bakkt closed its SPAC merger with VPC Impact Acquisition Holdings.

Nucor Lead

Cramer: Now Is Not the Time to Sell Nucor Steel Stock

Upside remains for steelmaker even after key downgrade, as infrastructure spending is still in play in Washington.

Levi Strauss Lead

Levi Strauss Bullish on Next-Gen Retail

The direct-to-consumer stores focus on local personalization, customization and digitalization.

Wall Street Lead

Cramer's Mad Money Recap: J&J, Netflix, Nvidia, Tesla

Cramer says the clouds over Wall Street may have broken. Get ready for next week's earnings parade.

Here Is What Jim Cramer Expects From Schlumberger's Earnings

Energy Stocks Emerge as Leaders: Curran

Years of underperformance appear over for hard-hit oil and gas stocks.

Dave Chappelle Netflix Lead

Netflix Employee Reportedly Laid Off Over Chappelle Show Leak

Internal unrest over content of comedian's latest program continues at streaming giant.

crypto copy

Stablecoin Issuer Tether Agrees to $41 Million Settlement with CTFC

Tether made 'untrue or misleading statements and omissions in connection with the U.S. dollar tether token stablecoin,' the CFTC said.

Boeing Invests $20 Million in Human Spaceflight Company Virgin Galactic

Virgin Galactic Could Fall Another 15%. Chart Shows Where to Buy Dip.

Virgin Galactic stock had verged on a breakout. Now it's dropping. Here's where we're looking to buy the dip.